具有帕金森症的α-synucleinopathies和tauopathies的睡眠表型
Nils Briel1, Céline Marti2, Esther Werth2
1Department of Neurology, University Hospital Zurich, University of Zurich, Switzerland; Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Parkinsonism & related disorders
|November 5, 2025
概括
在帕金森症中,不同的睡眠模式可以区分α-synucleinopathy (Syn) 和tauopathy (Tau). 这些睡眠表型显示为蛋白质病变的非侵入性生物标志物具有前途.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 生物标志物发现发现
背景情况:
- 在帕金森症中需要对α-synucleinopathy (Syn) 和tauopathy (Tau) 的生物标志物.
- 快速眼动 (REM) 睡眠行为障碍 (RBD) 与Syn相关,但其他睡眠特征的作用尚不清楚.
- 这项研究调查了睡眠表型作为帕金森症中Syn和Tau的潜在生物标志物.
研究的目的:
- 为了评估神经退行性帕金森症的睡眠表型.
- 使用睡眠特征来区分Syn和Tau蛋白质病变.
- 探索睡眠表型作为非侵入性生物标志物的潜力.
主要方法:
- 对198名帕金森症患者的多睡眠记录的回顾性分析.
- 临床诊断和Syn与Tau组之间的睡眠特征的比较.
- 使用睡眠特征和人口统计学来区分Syn和Tau的后勤回归模型的开发.
主要成果:
- 陶氏患者比Syn患者表现出更大的睡眠结构障碍 (较少的REM,较少的N2睡眠,效率较低,在入睡后更多的觉醒).
- 斯特里多是多重系统性缩 (MSA) 患者 (42%的患病率) 的独特特征.
- 结合睡眠特征和人口统计数据的模型实现了高诊断准确性 (AUC=0.9) 来区分Syn和Tau.
结论:
- 独特的睡眠表型是帕金森症中Syn和Tau蛋白质病变的特征.
- 神经退行影响睡眠和清醒调节不同基于蛋白质病变的类型.
- 睡眠表型为帕金森症中Syn和Tau的非侵入性生物标志物提供了潜力.
关键词:
神经退行发生神经退行.帕金森 帕金森症候群多重睡眠学术 (Polysomnography) 是一种多重睡眠学术.RBD/REM睡眠行为障碍 睡眠行为障碍睡眠 睡眠 睡眠 睡眠塔乌·塔乌 (Tau Tau) 是一个α-synuclein 是一种同核蛋白.更多相关视频
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.6K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
11.2K
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment
963
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
963
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
